Compare Nuvoco Vistas with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.68%
- Poor long term growth as Net Sales has grown by an annual rate of 5.26% and Operating profit at 7.75% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.42 times
Flat results in Dec 25
Below par performance in long term as well as near term
Stock DNA
Cement & Cement Products
INR 11,120 Cr (Small Cap)
28.00
35
0.00%
0.61
2.98%
1.19
Total Returns (Price + Dividend) 
Nuvoco Vistas for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Nuvoco Vistas Corporation Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
Nuvoco Vistas Corporation Ltd’s investment rating has been upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The cement sector company’s recent performance and valuation metrics have been carefully analysed, revealing a mixed picture across quality, valuation, financial trends, and technical indicators that underpin this revised stance.
Read full news article
Nuvoco Vistas Corporation Ltd Technical Momentum Shifts Amid Mixed Market Signals
Nuvoco Vistas Corporation Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day gain of 0.13%, the cement sector stock faces a complex interplay of technical indicators that suggest cautious optimism tempered by persistent headwinds.
Read full news article Announcements 
Board Meeting Intimation for Considering And Approving Inter Alia The Audited Standalone And Consolidated Financial Results Of The Company For The Financial Year Ended March 31 2026.
07-Apr-2026 | Source : BSENuvoco Vistas Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/04/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the financial year ended March 31 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
07-Apr-2026 | Source : BSEPursuant to Regulation 30 read with Para A of Part A of Schedule III of the Listing Regulations SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31 2024 we would like to inform that an Investor and Analyst Conference Call on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2026 is scheduled to be held on Wednesday April 15 2026 at 4:30 p.m. (IST).
Closure of Trading Window
31-Mar-2026 | Source : BSEPlease refer the attachment.
Corporate Actions 
14 Apr 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 18 Schemes (17.92%)
Held by 134 FIIs (5.0%)
Niyogi Enterprise Private Limited (60.16%)
Sbi Flexicap Fund (8.75%)
4.18%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 9.92% vs -14.45% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 34.64% vs -72.64% in Sep 2025







